Alimentiv, Summit Clinical Research Collaborate to Support Non-Alcoholic Steatohepatitis Clinical Trials
Alimentiv and Summit Clinical Research are collaborating to drive Non-Alcoholic Steatohepatitis drug development programs forward.
Read MorePosted by Andy Lundin | Nov 3, 2022 | Diabetes & Metabolic Diseases |
Alimentiv and Summit Clinical Research are collaborating to drive Non-Alcoholic Steatohepatitis drug development programs forward.
Read MorePosted by Chris Wolski | Nov 2, 2022 | Company News |
Nordic Capital and Five Arrows have entered into a definitive agreement to sell The Binding Site to Thermo Fisher Scientific.
Read MorePosted by Andy Lundin | Nov 1, 2022 | Melanoma |
Proscia released study results on new AI that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer.
Read MorePosted by Chris Wolski | Oct 27, 2022 | Digital Pathology |
Digital innovations are shifting the role of laboratory medicine and represent a new paradigm in standard of care.
Read MorePosted by Andy Lundin | Oct 24, 2022 | Emerging & Zoonotic Diseases |
GlycoPath’s proprietary technology was used to distinguish between Lyme disease infection states and track treatment response.
Read More